COVID-19 Impact on Global Dabigatran Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: CAD4B3D0CE49EN
QYResearch

Abstracts

This report focuses on the global Dabigatran status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dabigatran development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Bayer Healthcare
• GlaxoSmithKline
• Boehringer Ingelheim
• Aspen Holdings
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries
• ...

Market segment by Type, the product can be split into

• Tablets
• Capsule
• Others

Market segment by Application, split into

• Deep Vein Thrombosis
• Pulmonary Embolism
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Dabigatran status, future forecast, growth opportunity, key market and key players.
• To present the Dabigatran development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Dabigatran are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dabigatran Revenue
1.4 Market Analysis by Type
  1.4.1 Global Dabigatran Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tablets
  1.4.3 Capsule
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Dabigatran Market Share by Application: 2020 VS 2026
  1.5.2 Deep Vein Thrombosis
  1.5.3 Pulmonary Embolism
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Dabigatran Industry Impact
  1.6.1 How the Covid-19 is Affecting the Dabigatran Industry
    1.6.1.1 Dabigatran Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Dabigatran Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Dabigatran Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Dabigatran Market Perspective (2015-2026)
2.2 Dabigatran Growth Trends by Regions
  2.2.1 Dabigatran Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Dabigatran Historic Market Share by Regions (2015-2020)
  2.2.3 Dabigatran Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Dabigatran Market Growth Strategy
  2.3.6 Primary Interviews with Key Dabigatran Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Dabigatran Players by Market Size
  3.1.1 Global Top Dabigatran Players by Revenue (2015-2020)
  3.1.2 Global Dabigatran Revenue Market Share by Players (2015-2020)
  3.1.3 Global Dabigatran Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dabigatran Market Concentration Ratio
  3.2.1 Global Dabigatran Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Dabigatran Revenue in 2019
3.3 Dabigatran Key Players Head office and Area Served
3.4 Key Players Dabigatran Product Solution and Service
3.5 Date of Enter into Dabigatran Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Dabigatran Historic Market Size by Type (2015-2020)
4.2 Global Dabigatran Forecasted Market Size by Type (2021-2026)

5 DABIGATRAN BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Dabigatran Market Size by Application (2015-2020)
5.2 Global Dabigatran Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Dabigatran Market Size (2015-2020)
6.2 Dabigatran Key Players in North America (2019-2020)
6.3 North America Dabigatran Market Size by Type (2015-2020)
6.4 North America Dabigatran Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Dabigatran Market Size (2015-2020)
7.2 Dabigatran Key Players in Europe (2019-2020)
7.3 Europe Dabigatran Market Size by Type (2015-2020)
7.4 Europe Dabigatran Market Size by Application (2015-2020)

8 CHINA

8.1 China Dabigatran Market Size (2015-2020)
8.2 Dabigatran Key Players in China (2019-2020)
8.3 China Dabigatran Market Size by Type (2015-2020)
8.4 China Dabigatran Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Dabigatran Market Size (2015-2020)
9.2 Dabigatran Key Players in Japan (2019-2020)
9.3 Japan Dabigatran Market Size by Type (2015-2020)
9.4 Japan Dabigatran Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Dabigatran Market Size (2015-2020)
10.2 Dabigatran Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dabigatran Market Size by Type (2015-2020)
10.4 Southeast Asia Dabigatran Market Size by Application (2015-2020)

11 INDIA

11.1 India Dabigatran Market Size (2015-2020)
11.2 Dabigatran Key Players in India (2019-2020)
11.3 India Dabigatran Market Size by Type (2015-2020)
11.4 India Dabigatran Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Dabigatran Market Size (2015-2020)
12.2 Dabigatran Key Players in Central & South America (2019-2020)
12.3 Central & South America Dabigatran Market Size by Type (2015-2020)
12.4 Central & South America Dabigatran Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Dabigatran Introduction
  13.1.4 Pfizer Revenue in Dabigatran Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Bayer Healthcare
  13.2.1 Bayer Healthcare Company Details
  13.2.2 Bayer Healthcare Business Overview and Its Total Revenue
  13.2.3 Bayer Healthcare Dabigatran Introduction
  13.2.4 Bayer Healthcare Revenue in Dabigatran Business (2015-2020)
  13.2.5 Bayer Healthcare Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Dabigatran Introduction
  13.3.4 GlaxoSmithKline Revenue in Dabigatran Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Boehringer Ingelheim
  13.4.1 Boehringer Ingelheim Company Details
  13.4.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.4.3 Boehringer Ingelheim Dabigatran Introduction
  13.4.4 Boehringer Ingelheim Revenue in Dabigatran Business (2015-2020)
  13.4.5 Boehringer Ingelheim Recent Development
13.5 Aspen Holdings
  13.5.1 Aspen Holdings Company Details
  13.5.2 Aspen Holdings Business Overview and Its Total Revenue
  13.5.3 Aspen Holdings Dabigatran Introduction
  13.5.4 Aspen Holdings Revenue in Dabigatran Business (2015-2020)
  13.5.5 Aspen Holdings Recent Development
13.6 Bristol-Myers Squibb Company
  13.6.1 Bristol-Myers Squibb Company Company Details
  13.6.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.6.3 Bristol-Myers Squibb Company Dabigatran Introduction
  13.6.4 Bristol-Myers Squibb Company Revenue in Dabigatran Business (2015-2020)
  13.6.5 Bristol-Myers Squibb Company Recent Development
13.7 Teva Pharmaceutical Industries
  13.7.1 Teva Pharmaceutical Industries Company Details
  13.7.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
  13.7.3 Teva Pharmaceutical Industries Dabigatran Introduction
  13.7.4 Teva Pharmaceutical Industries Revenue in Dabigatran Business (2015-2020)
  13.7.5 Teva Pharmaceutical Industries Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Dabigatran Key Market Segments
Table 2. Key Players Covered: Ranking by Dabigatran Revenue
Table 3. Ranking of Global Top Dabigatran Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dabigatran Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablets
Table 6. Key Players of Capsule
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Dabigatran Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Dabigatran Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Dabigatran Players to Combat Covid-19 Impact
Table 13. Global Dabigatran Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Dabigatran Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Dabigatran Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Dabigatran Market Share by Regions (2015-2020)
Table 17. Global Dabigatran Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Dabigatran Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Dabigatran Market Growth Strategy
Table 23. Main Points Interviewed from Key Dabigatran Players
Table 24. Global Dabigatran Revenue by Players (2015-2020) (Million US$)
Table 25. Global Dabigatran Market Share by Players (2015-2020)
Table 26. Global Top Dabigatran Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dabigatran as of 2019)
Table 27. Global Dabigatran by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Dabigatran Product Solution and Service
Table 30. Date of Enter into Dabigatran Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 33. Global Dabigatran Market Size Share by Type (2015-2020)
Table 34. Global Dabigatran Revenue Market Share by Type (2021-2026)
Table 35. Global Dabigatran Market Size Share by Application (2015-2020)
Table 36. Global Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 37. Global Dabigatran Market Size Share by Application (2021-2026)
Table 38. North America Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Dabigatran Market Share (2019-2020)
Table 40. North America Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 41. North America Dabigatran Market Share by Type (2015-2020)
Table 42. North America Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 43. North America Dabigatran Market Share by Application (2015-2020)
Table 44. Europe Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Dabigatran Market Share (2019-2020)
Table 46. Europe Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Dabigatran Market Share by Type (2015-2020)
Table 48. Europe Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Dabigatran Market Share by Application (2015-2020)
Table 50. China Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 51. China Key Players Dabigatran Market Share (2019-2020)
Table 52. China Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 53. China Dabigatran Market Share by Type (2015-2020)
Table 54. China Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 55. China Dabigatran Market Share by Application (2015-2020)
Table 56. Japan Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Dabigatran Market Share (2019-2020)
Table 58. Japan Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Dabigatran Market Share by Type (2015-2020)
Table 60. Japan Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Dabigatran Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Dabigatran Market Share (2019-2020)
Table 64. Southeast Asia Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Dabigatran Market Share by Type (2015-2020)
Table 66. Southeast Asia Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Dabigatran Market Share by Application (2015-2020)
Table 68. India Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 69. India Key Players Dabigatran Market Share (2019-2020)
Table 70. India Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 71. India Dabigatran Market Share by Type (2015-2020)
Table 72. India Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 73. India Dabigatran Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Dabigatran Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Dabigatran Market Share (2019-2020)
Table 76. Central & South America Dabigatran Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Dabigatran Market Share by Type (2015-2020)
Table 78. Central & South America Dabigatran Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Dabigatran Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Bayer Healthcare Company Details
Table 86. Bayer Healthcare Business Overview
Table 87. Bayer Healthcare Product
Table 88. Bayer Healthcare Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 89. Bayer Healthcare Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Boehringer Ingelheim Company Details
Table 96. Boehringer Ingelheim Business Overview
Table 97. Boehringer Ingelheim Product
Table 98. Boehringer Ingelheim Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 99. Boehringer Ingelheim Recent Development
Table 100. Aspen Holdings Company Details
Table 101. Aspen Holdings Business Overview
Table 102. Aspen Holdings Product
Table 103. Aspen Holdings Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 104. Aspen Holdings Recent Development
Table 105. Bristol-Myers Squibb Company Company Details
Table 106. Bristol-Myers Squibb Company Business Overview
Table 107. Bristol-Myers Squibb Company Product
Table 108. Bristol-Myers Squibb Company Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Company Recent Development
Table 110. Teva Pharmaceutical Industries Company Details
Table 111. Teva Pharmaceutical Industries Business Overview
Table 112. Teva Pharmaceutical Industries Product
Table 113. Teva Pharmaceutical Industries Revenue in Dabigatran Business (2015-2020) (Million US$)
Table 114. Teva Pharmaceutical Industries Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Dabigatran Market Share by Type: 2020 VS 2026
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Others Features
Figure 5. Global Dabigatran Market Share by Application: 2020 VS 2026
Figure 6. Deep Vein Thrombosis Case Studies
Figure 7. Pulmonary Embolism Case Studies
Figure 8. Others Case Studies
Figure 9. Dabigatran Report Years Considered
Figure 10. Global Dabigatran Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Dabigatran Market Share by Regions: 2020 VS 2026
Figure 12. Global Dabigatran Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Dabigatran Market Share by Players in 2019
Figure 15. Global Top Dabigatran Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dabigatran as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Dabigatran Revenue in 2019
Figure 17. North America Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Dabigatran Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 26. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bayer Healthcare Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 30. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boehringer Ingelheim Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 32. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Aspen Holdings Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 34. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bristol-Myers Squibb Company Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 36. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Teva Pharmaceutical Industries Revenue Growth Rate in Dabigatran Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed